Structures by: Xing H. H.
Total: 4
C14H16N2OS
C14H16N2OS
Organic letters (2017) 19, 18 4952-4955
a=6.1830(7)Å b=11.5573(13)Å c=17.814(2)Å
α=90° β=90° γ=90°
Diaquabis(2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylato- κ^2^<i>O</i>,<i>O</i>)cobalt(II)
C10H10CoN4O10
Acta Crystallographica Section E (2007) 63, 9 m2267-m2267
a=5.0608(6)Å b=15.087(2)Å c=9.2900(10)Å
α=90.00° β=99.3890(10)° γ=90.00°
(μ-6-Oxido-4-oxo-1,2-dihydropyrimidine-5-carboxylato- κ^4^<i>O</i>^5^,<i>O</i>^6^:<i>O</i>^2^,<i>N</i>^3^)bis[aquabis(4-oxido- 2-oxo-1,2-dihydropyrimidin-3-ium-5-carboxylato- κ^2^<i>O</i>^4^,<i>O</i>^5^)(1,10-phenanthroline- κ^2^<i>N</i>,<i>N</i>)neodymium(III)] hexahydrate
[Nd2(C5H2N2O4)(C5H3N2O4)4(C12H8N2)2(H2O)2],6H2O
Acta Crystallographica Section E (2008) 64, 2 m419-m420
a=10.1980(7)Å b=12.8896(9)Å c=13.3383(9)Å
α=118.7110(10)° β=90.0100(10)° γ=108.6120(10)°
(6-Oxido-2-oxo-1,2-dihydropyrimidine-5-carboxylato- κ^2^<i>O</i>^5^,<i>O</i>^6^)(4-oxido-2-oxo-1,2-dihydropyrimidin-3-ium-5- carboxylato-κ^2^<i>O</i>^4^,<i>O</i>^5^)bis(1,10-phenanthroline- κ^2^<i>N</i>,<i>N</i>)erbium(III) dihydrate
C34H21ErN8O8,2(H2O)
Acta Crystallographica Section E (2008) 64, 2 m418-m418
a=17.1602(7)Å b=14.4170(6)Å c=13.2433(5)Å
α=90.00° β=101.1590(10)° γ=90.00°